- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02512705
Medical Monitoring for Agitated Patients Pilot RCT - Medical Monitoring
29. juli 2015 oppdatert av: Janet Patterson, St. Joseph's Healthcare Hamilton
A Pilot Randomized Control Trial: The Ability to Medically Monitor With Use of Physical and Chemical Restraints or Seclusion of Acutely Agitated or Violent Patients Who Present to the Psychiatric Emergency Services
The Psychiatric Emergency Services (PES) is an under researched area of clinical practice, largely in the management of acutely agitated and violent patients.
The goal of this pilot randomized clinical trial (RCT) is to assess the benefit of medically monitoring patients that present with extreme agitation and/or violent behaviour to PES.
Placing them in physical restraints and immediately administering chemical restraint, will enable medical monitoring of these potentially medically unstable patients.
Investigators believe that this practice will provide safer management of patients, reduce risk to staff and other patients, reduce risk of undiagnosed medical conditions that underly the agitation, and increase clinical management and quality of care.
Patients that come into the Emergency Department that are agitated and violent, where verbal-deescalation will not suffice, will be randomly treated with either immediate placement in seclusion (current practice) or be placed in physical restraints and given chemical restraint (as outlined in the BETA project guidelines).
The same time interval assessments will be performed on both groups of patients including; medical monitoring and agitation scale assessment.
Data will also be collected on number of violent episodes, code whites, required increase in the use of physical restraints, length of intervention, and more.
This assessment will enable a comparison between the current practice and the proposed practice to establish evidence based clinical guidelines for the management of acute agitation in PES, where de-escalation techniques are ineffective and the lack of medical monitoring is harmful to the patient and can negatively effect their outcome.
In order to best assess the importance of medical monitoring for such patients, a pilot study must be performed to assess the feasibility of such a phase III RCT study.
Studieoversikt
Status
Ukjent
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Forventet)
90
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Was agitated or violent upon entry into PES.
- Is 18+ years of age.
- Verbal de-escalation techniques are not useful for management of this patient.
- BETA Project techniques alone are not useful for management of this patient.
- The patient is assigned a CTAS1 or CTAS2 score.
Exclusion Criteria:
- The patient scores a "Low" or "Moderate" level of risk on the Violence/Aggression Screening Tool (VAST) that is used at ER triage.
- The point of agitation or violence began after the patient was already admitted to PES.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Annen: Seclusion Room
The current practice is followed as a control group A.
|
|
|
Eksperimentell: Physical Restraint
Patient is placed in physical restraints to enable delivery of chemical restraints and medical monitoring and is monitored 1:1.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Analysis of feasibility, as measured by the recruitment rates
Tidsramme: 3 months
|
Process
|
3 months
|
|
Analysis of feasibility, as measured by staff and resource availability
Tidsramme: 3 months
|
Resources
|
3 months
|
|
Analysis of feasibility, as measured by baseline data of demographic and clinical characteristics
Tidsramme: 3 months
|
Scientific
|
3 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Occurrence of medical event
Tidsramme: 3 months
|
Were there any medical events?
What was the time to the first medical event?
|
3 months
|
|
Time to medical event response
Tidsramme: 3 months
|
What was the time taken to respond to a medical event from the start of the intervention?
|
3 months
|
|
Time of agitation event response
Tidsramme: 3 months
|
What was the time it took to respond to an agitation event?
|
3 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. september 2015
Primær fullføring (Forventet)
1. desember 2015
Studiet fullført (Forventet)
1. april 2016
Datoer for studieregistrering
Først innsendt
23. juli 2015
Først innsendt som oppfylte QC-kriteriene
29. juli 2015
Først lagt ut (Anslag)
31. juli 2015
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
31. juli 2015
Siste oppdatering sendt inn som oppfylte QC-kriteriene
29. juli 2015
Sist bekreftet
1. juli 2015
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Patterson-1
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .